Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 NK cells
Evan Shereck, Nancy S Day, Aradhana Awasthi, Janet Ayello, Yaya Chu, Catherine McGuinn, Carmella van de Ven, Megan S Lim, Mitchell S Cairo
Published in Innate immunity (London, England) (01.07.2019)
Published in Innate immunity (London, England) (01.07.2019)
Get full text
Journal Article
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56Dim NK cells
Shereck, Evan, Day, Nancy S, Awasthi, Aradhana, Ayello, Janet, Chu, Yaya, McGuinn, Catherine, van de Ven, Carmella, Lim, Megan S, Cairo, Mitchell S
Published in Innate immunity (London, England) (01.07.2019)
Published in Innate immunity (London, England) (01.07.2019)
Get full text
Journal Article
Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes
Awasthi, Aradhana, Samarakoon, Asanga, Chu, Haiyan, Kamalakannan, Rajasekaran, Quilliam, Lawrence A, Chrzanowska-Wodnicka, Magdalena, White, 2nd, Gilbert C, Malarkannan, Subramaniam
Published in The Journal of experimental medicine (30.08.2010)
Published in The Journal of experimental medicine (30.08.2010)
Get full text
Journal Article
Abstract 2381: Blinatumomab enhanced anti-tumor activity against rituximab sensitive and resistant Burkitt Lymphoma (BL) and Primary Mediastinal B-cell Lymphoma (PMBL)
Tiwari, Aradhana Awasthi, Edani, Dina, Ayello, Janet, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 1537: Polatuzumab Vedotin alone or in-combination with anti-CD20 antibody significantly enhanced overall survival in xenografted NSG mice against rituximab sensitive and resistant Burkitt Lymphoma (BL) and Primary Mediastinal B-cell Lymphoma (PMBL)
Tiwari, Aradhana Awasthi, Edani, Dina, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Awasthi, Aradhana, Ayello, Janet, Van de Ven, Carmella, Elmacken, Mona, Sabulski, Anthony, Barth, Matthew J., Czuczman, Myron S., Islam, Humayun, Klein, Christian, Cairo, Mitchell S.
Published in British journal of haematology (01.12.2015)
Published in British journal of haematology (01.12.2015)
Get full text
Journal Article
Abstract 1788: Enhanced in vitro/in vivo cytotoxicity against Burkitt lymphoma/primary mediastinal large B cell lymphoma by polatuzumab vedotin (hu- anti-CD79b-vc-MMAE, PV) alone or in combination with obinutuzumab
Tiwari, Aradhana Awasthi, Edani, Dina, Azmy, Christeen, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can Be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Elmacken, Mona, MD, Awasthi, Aradhana, PhD, Ayello, Janet, MS, MT(ASCP), van de Ven, Carmella, MS, Luo, Wen, PhD, Liao, Yanling, PhD, Riddell, Stanley, MD, Cairo, Mitchell S., MD
Published in Biology of blood and marrow transplantation (01.02.2015)
Published in Biology of blood and marrow transplantation (01.02.2015)
Get full text
Journal Article
Abstract 2565: EBV peptide-derived vaccine significantly enhanced in vitro cytotoxicity against EBV-positive B-cell lymphoma (EBV-BL) treatment using TMV-based delivery system
Tiwari, Aradhana Awasthi, McCormick, Alison, Edani, Dina, Newman, Aaron, Azmy, Christeen, Ayello, Janet, Klein, Christian, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Polatuzumab Vedotin; Antibody Drug Conjugates (ADC, anti-CD79b-vc-MMAE, PV) Significantly Enhances in-Vitro Cell Death Against CD79b+ Burkitt Lymphoma (BL) /Primary Mediastinal Large B Cell Lymphoma (PMBL) and Improved Overall Survival Against Rituximab Sensitive/Resistant-BL NSG Xenograft Mice
Awasthi, Aradhana, Ayello, Janet, van de Ven, Carmella, Love, Asana, Cairo, Mitchell S.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
Chu, Yaya, Awasthi, Aradhana, Lee, Sanghoon, Edani, Dina, Yin, Changhong, Hochberg, Jessica, Shah, Tishi, Chung, Tae-Hoon, Ayello, Janet, Ven, Carmella van de, Klein, Christian, Lee, Dean, Cairo, Mitchell S.
Published in Oncotarget (11.08.2020)
Published in Oncotarget (11.08.2020)
Get full text
Journal Article
Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56 Dim NK cells
Shereck, Evan, Day, Nancy S, Awasthi, Aradhana, Ayello, Janet, Chu, Yaya, McGuinn, Catherine, van de Ven, Carmella, Lim, Megan S, Cairo, Mitchell S
Published in Innate immunity (London, England) (01.07.2019)
Published in Innate immunity (London, England) (01.07.2019)
Get full text
Journal Article
IQGAP1: a regulator of intracellular spacetime relativity
Malarkannan, Subramaniam, Awasthi, Aradhana, Rajasekaran, Kamalakannan, Kumar, Pawan, Schuldt, Kristina M, Bartoszek, Allison, Manoharan, Niranjan, Goldner, Nicholas K, Umhoefer, Colleen M, Thakar, Monica S
Published in The Journal of immunology (1950) (01.03.2012)
Published in The Journal of immunology (1950) (01.03.2012)
Get full text
Journal Article
Abstract 3155: Neuroblastoma (NB), Medulloblastoma (MB), and Ewing's sarcoma (ES) express ROR1 and can be effectively targeted with NK cells modified to express an anti ROR1 chimeric antigen receptor (CAR)
Elmacken, Mona, Awasthi, Aradhana, Ayello, Janet, VanDeVen, Carmella, Luo, Wen, Liao, Yanling, Riddell, Stanley, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 2479: Obinutuzumab compared to Rituximab significantly enhances cell death, antibody dependent cytotoxicity (ADCC) and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt Lymphoma (BL) and precursor Lymphoblastic L
Tiwari, Aradhana Awasthi, Ayello, Janet, Vandeven, Carmella, Elmacken, Mona, Barth, Matthew J., Klein, Christian, Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract 579: Antibody drug conjugates (anti-CD79b-vc-MMAE, Polatuzumab Vedotin) exhibit enhanced cell death targeted to CD79b+ Burkitt lymphoma (BL) and primary mediastinal large B-cell lymphoma (PMBL)
Tiwari, Aradhana Awasthi, Ayello, Janet, van de Ven, Carmella, Kurien, Lisa, Barth, Matthew J., Cairo, Mitchell S.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Comparative Study of Obinutuzumab (GA101) Vs. Rituximab Against CD20+ rituximab-Sensitive and -Resistant Burkitt (BL) and Acute Lymphoblastic Leukemia (B-ALL): Potential Targeted Therapy in Patients with High Risk BL and Pre-B-ALL
Awasthi, Aradhana, Ayello, Janet, van de Ven, Carmella, Elmacken, Mona, Reggio, Christopher, Barth, Matthew J., Cairo, Mitchell S.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Obinutuzumab (GA101) Significantly Improves Survival In CD20 Positive Pre-B Cell Lymphoblastic Leukemia (pre-B-ALL) Xenograft Models Compared To Rituximab (RTX): Potential Targeted Therapy In Patients With High Risk Pre-B-ALL
Awasthi, Aradhana, Ayello, Janet, Ven, Carmella van de, Hovy, Stefan, Cairo, Mitchell S.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article